MAIA Biotechnology MAIA
NYSE MAIA
$1.30 -0.03 (-2.18%)
As of: Sep 10, 2026 · 3:59 PM EDT

MAIA Biotechnology (MAIA) Interest Coverage Ratio (2021 - 2024)

MAIA Biotechnology's (MAIA) quarterly Interest Coverage Ratio came in at 178735.86 in Q4 2024, up 462.72% quarter-over-quarter from 49276.09 in Q3 2024.

Analysis

MAIA Biotechnology (MAIA) Interest Coverage Ratio (2021 - 2024) Analysis & Trends

MAIA Biotechnology (MAIA) has reported Interest Coverage Ratio for 4 consecutive years, with 178735.86 the latest figure, recorded in Q4 2024.

  • On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 178735.86 in Q4 2024; TTM through Dec 2024 was 292365.69, a 9841.87% decrease from a year earlier, with the FY2024 full-year figure at 297494.91, down 10016.29% from the prior year.
  • Interest Coverage Ratio was 178735.86 for Q4 2024 at MAIA Biotechnology, up from 49276.09 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 178735.86 in Q4 2024 and troughed at 4955643.0 in Q3 2023.
  • A 4-year average of 540733.57 and a median of 2719.91 in 2023 frame the typical range for Interest Coverage Ratio.
  • Across the five-year window, Interest Coverage Ratio tumbled 166787.25% in 2023 and jumped 99.01% in 2024, its largest moves.
  • Over 4 years, Interest Coverage Ratio stood at 4.95 in 2021, then tumbled by 16370.75% to 815.04 in 2022, then slumped by 607924.21% to 4955643.0 in 2023, then soared by 103.61% to 178735.86 in 2024.
  • The last three Interest Coverage Ratio figures came in at 178735.86 (Q4 2024), 49276.09 (Q3 2024), and 4955643.0 (Q3 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 5.22
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -42.08
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 117.59
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 493.00
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 2.82
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 MAIA Biotechnology 79.34 Mn 51.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 178,735.86
Sep 30, 2024 -49,276.09
Sep 30, 2023 -4.96 Mn
Jun 30, 2023 -2,719.91
Mar 31, 2023 -812.95
Dec 31, 2022 -815.04
Sep 30, 2022 -2,969.46
Jun 30, 2022 -33,096.58
Sep 30, 2021 -4.95